155 related articles for article (PubMed ID: 27984583)
1. Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
Puigvehí M; Hernández J; Broquetas T; Coll S; Garcia-Retortillo M; Cañete N; Giménez MD; Garcia M; Bory F; Salvadó M; Solà R; Carrión JA
PLoS One; 2016; 11(12):e0164883. PubMed ID: 27984583
[TBL] [Abstract][Full Text] [Related]
2. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
3. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.
Omran D; Yosry A; Darweesh SK; Nabeel MM; El-Beshlawey M; Saif S; Fared A; Hassany M; Zayed RA
Clin Exp Med; 2018 Feb; 18(1):45-50. PubMed ID: 28567544
[TBL] [Abstract][Full Text] [Related]
4. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
[TBL] [Abstract][Full Text] [Related]
5. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
[TBL] [Abstract][Full Text] [Related]
6. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
7. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children.
Nassef YE; Shady MM; Galal EM; Hamed MA
Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):887-93. PubMed ID: 24141960
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
9. European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis.
Abignano G; Blagojevic J; Bissell LA; Dumitru RB; Eng S; Allanore Y; Avouac J; Bosello S; Denton CP; Distler O; Ferraccioli G; Jordan S; Matucci-Cerinic M; Ong V; Messenger M; Hutchinson M; Buch MH; Emery P; Del Galdo F
Rheumatology (Oxford); 2019 Feb; 58(2):254-259. PubMed ID: 30239834
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.
Parkes J; Guha IN; Roderick P; Harris S; Cross R; Manos MM; Irving W; Zaitoun A; Wheatley M; Ryder S; Rosenberg W
J Viral Hepat; 2011 Jan; 18(1):23-31. PubMed ID: 20196799
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C.
Catanzaro R; Milazzo M; Arona S; Sapienza C; Vasta D; Arcoria D; Marotta F
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):500-7. PubMed ID: 24103280
[TBL] [Abstract][Full Text] [Related]
12. [Possibility of Using ELF Score as Index for Hepatic Fibrosis Evaluation].
Asano H
Rinsho Byori; 2015 Jan; 63(1):78-83. PubMed ID: 26524882
[TBL] [Abstract][Full Text] [Related]
13. Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis.
Gunes Yegin E; Durusoy SS; Ture Ozdemir F; Kombak EF; Ataizi-Celikel C; Ozdogan OC
Ann Hepatol; 2019; 18(6):833-840. PubMed ID: 31558418
[TBL] [Abstract][Full Text] [Related]
14. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
15. Can the Enhanced Liver Fibrosis Score Be Used to Diagnose Children With Liver Fibrosis?
Thusing I; Antonsen S; Hoffmann-Petersen BS; Rasmussen HM; Wittenhagen P
J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):186-191. PubMed ID: 34620760
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis.
Lidbury JA; Hoffmann AR; Fry JK; Suchodolski JS; Steiner JM
Can J Vet Res; 2016 Oct; 80(4):302-308. PubMed ID: 27733785
[TBL] [Abstract][Full Text] [Related]
17. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis.
Sharma C; Cococcia S; Ellis N; Parkes J; Rosenberg W
J Gastroenterol Hepatol; 2021 Jul; 36(7):1788-1802. PubMed ID: 33668077
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.
Tanwar S; Trembling PM; Hogan BJ; Srivastava A; Parkes J; Harris S; Grant P; Nastouli E; Ocker M; Wehr K; Herold C; Neureiter D; Schuppan D; Rosenberg WM
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):289-296. PubMed ID: 27906753
[TBL] [Abstract][Full Text] [Related]
20. Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.
Kawashiri SY; Origuchi T; Umeda M; Nishino A; Shimizu T; Fukui S; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Maeda T; Kawano M; Yamamoto M; Izumi Y; Kawakami A
Arthritis Res Ther; 2018 Dec; 20(1):277. PubMed ID: 30547825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
